Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) Return on Capital Employed (2016 - 2025)

Avricore Health has reported Return on Capital Employed over the past 10 years, most recently at 177.8% for Q4 2025.

  • Quarterly Return on Capital Employed fell 18336.0% to 177.8% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 177.8% through Dec 2025, down 18336.0% year-over-year, with the annual reading at 108.01% for FY2025, 11414.0% down from the prior year.
  • Return on Capital Employed was 177.8% for Q4 2025 at Avricore Health, down from 57.32% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 5.57% in Q4 2024 and troughed at 177.8% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 15.88% (2022), against an average of 25.64%.
  • Year-over-year, Return on Capital Employed skyrocketed 4575bps in 2024 and then crashed -18336bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 6.74% in 2021, then plummeted by -465bps to 38.03% in 2022, then skyrocketed by 50bps to 19.09% in 2023, then skyrocketed by 129bps to 5.57% in 2024, then plummeted by -3294bps to 177.8% in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Return on Capital Employed are 177.8% (Q4 2025), 57.32% (Q3 2025), and 34.85% (Q2 2025).